Dilation and evacuation with intrauterine device placement in a patient with acute promyelocytic leukemia: A case report

Introduction: Pregnant leukemia patients should be offered continuation or termination of pregnancy. Treatment in reproductive-age includes consideration contraception. Hormonal intrauterine devices (IUDs) prevent pregnancy and decrease menstrual bleeding. Despite safety data for IUDs immunocompromised patients, infection vaginal bleeding concerns may inhibit their placement. Case Report: We report a case 28-year-old female at 13 weeks 4 days gestation with acute promyelocytic (APL) who presented coagulopathy. When stabilized, dilation evacuation (D E) levonorgestrel IUD placement was performed. The postoperative course uncomplicated. chemotherapy neutropenia, this APL patient tolerated D E well only routine preoperative antibiotics. Conclusion: Comprehensive options counseling pregnant new diagnoses are imperative, interdisciplinary risks individual prevention during treatment teratogenic potential, avoidance combined hormonal contraception (CHC) coagulopathy risk, reduction the setting pancytopenia management considered.